Asthma Flashcards

1
Q

Clinical Presentation

A
  • Episodes of SOB, chest tightness, coughing (mostly at night), wheezing
    -exercise, spontaneous, allergen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Agents & Events Triggering Exacerbations

A

-Resp. infections
-Allergens
-Environment
-Emotions
-Exercise
-Job stimuli (dust, spice, mold, chemicals)
-Host factors (AA, hispanic, obesity)

Drugs
-Acet, Aspirin, NSAIDs
-NS BB = carvedilol/propranolol/labadolol
-Sulfites
-Benza chloride
BANANS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

In asthma, reversibility is shown by an increase in _____ after SABA

A

FEV1 >12%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Asthma Sx Control

A

In the last 4 weeks:
-Daytime sx more than twice a week?
-Waking up at night?
-SABA used more than twice a week?
-Activity limitation?

  1. Well controlled: none
  2. Partly controlled: 1-2
  3. Uncontrolled: 3-4
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Treatment GOALS

A

Goals
-few asthma sx, no sleep disturbance, no exercise limitation
-maintain normal lung function
-prevent flare ups / asthma deaths
-minimize side effects

Assess
-take every opportunity to assess, routine visit once a year but also when pts get refill or are having sx

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

12+ Adults - Track 1: Preferred Controller and Reliever

A

1-2. As needed only Symbicort (12 puffs max)
3. Maintenance Symbicort 2 puffs twice a day of 80/4.5 AND as needed Symbicort
4. Maintenance 160/4.5 Symbicort AND as needed Symbicort
5. Symbicort 160/4.5 PLUS Spiriva PLUS as needed Symbicort reliever
-OR Trelegy, SABA or SABA ISC reliever
*Refer - type 2 phenotype: add biologic therapy

START AT IF
1-2. less than 4-5 days a wk
3. sx most days, waking with asthma
4. daily sx, waking with asthma, low lung function

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

12+ Adults - Track 2: Alternative Controller and Reliever

A

2 inhlaers needed
-Controller
-Reliever: ProAir (albuterol) or AirSuptra

  1. Take ICS whenever SABA taken
  2. Low dose maintenance ICS (Flovent diskus, Flovent HFA, or QVAR)
  3. Low dose ICS LABA (Dulera or Symbicort)
  4. Medium/high dose ICS LABA (Dulera or Symbicort)
  5. Add Spiriva or switch to Trelegy
    *refer - biologics therapy

Other Controller Options
-LTRA: Singular/Montelukast (ex)
-Can add azithromycin in step 5 for adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Track 1 Advice

A

-Emphasize that they should use ICS formoterol instead of previous SABA and additional inhaler with more sx
-1 at home, 1 to go
-Rinse and spit out after maintenance doses (not needed for reliever)

Difficult to Tx/Severe
-Refer to specialist
-Blood Eosinophils/FeNO
-Biologics if tx already optimized
-Maintenance OCS as last resort

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

6-11 yo Children Track

A
  1. low dose ICS taken whenever SABA taken (FQ + ALB)
  2. daily low dose ICS (FQ)
  3. low dose ICS LABA or medium dose ICS, or low dose ICS formoterol (FQ OR SYM/DU)
  4. medium dose ICS LABA or low dose ICS formoterol (DU OR SYM)
  5. Refer, phenotype assess, high dose ICS LABA, biologic therapy

Reliever
-As needed SABA (or ICS formoterol for MART only in step 3-4)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Follow Ups

A
  • Patients should be seen 1-3 months after starting treatment & every 3-12 months thereafter
  • Every 4-6 weeks in pregnancy
  • After an exacerbation, within 1 week

New med: 1-2 weeks, 1 month max

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Stepping Up

A

Short term step up
-for 1-2 weeks during viral infection or allergen exposure

Sustained step up
-for 2-3 months if sx persist
-assess technique, adherence, risk factors, conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Consider stepping down when:

A
  • Good asthma control has been achieved and maintained for 2–3 months
  • If asthma is well controlled on low-dose ICS or LTRA, as- needed low-dose ICS-formoterol is a step-down option
  • Do not completely withdraw ICS, except if needed temporarily while confirming the diagnosis of asthma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Management of Exacerbation in Primary Care

A

Mild or Mod
-SABA 4-10 puffs every 20 min for 1 hr
-Prednisolone: 40-50 mg for adults (5-7 days), 1-2 mg/kg for children (40 max, 3-5 days)
-Oxygen

Severe or Life Threat
-Transfer to acute care
-SABA, ipratropium bromide (Atrovent), oxygen, systemic CS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of Exacerbation in Acute Care (Emergency Department)

A

Mild or Mod
-SABA
-Ipro bromide (Atrovent)
-Oxygen
-Oral CS

Severe
-SABA
-Ipra bromide (Atrovent)
-Oxygen
-Oral or IV CS
*oral is as effective/preferred (quicker, less invasive, cheaper)
*BUT give IV if pt is too SOB to swallow or unconscious

Dose: prednisolone 50 mg as single dose or hydrocortisone 200 mg/day in divided doses

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Short Acting Beta-2 Agonists (SABA)

A

-Albuterol (ProAir, Ventolin)
-Levalbuterol (Xopenex®)

Adverse Effects:
-Nervousness
-Tremor
-Tachycardia
-HA
-N/V
-Hypokalemia

NN TT HH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Short Acting Muscarinic Antagonists – SAMA Anticholinergics

A

-Ipratropium (Atrovent HFA)
*flare up only

Adverse Effects:
-Dry mouth
-Dizzy
-HA
-N/V
-Tremors

17
Q

Long Anti-Muscarinic Antagonist (LAMA)

A

-Tiopropium (SPIRIVA RESPIMAT®)

add on option for step 4-5

Adverse Effects:
-Dry mouth, urinary retention (uncommon)

18
Q

Inhaled Corticosteroids (ICS):

A

-Flovent (fluticasone)
-QVAR (beclomethasone)
-budesonide, ciclesonide, mometasone, triamcinolone

-most effective, primary
-most benefit at low doses

Adverse Effects:
-Hoarseness, cough, sore throat
-Risk of systemic AE

19
Q

Inhaled Long-Acting Beta-2 Agonists (LABA)

A

Serevent (salmeterol)

-NOT to be used as monotherapy
-Increase risk of respiratory failure death BBW
-Combined with ICS

20
Q

ICS-LABA

A

-Symbicort (budesonide-formoterol)

AE:
-LABA: tachy, HA, cramp, tremor
-ICS: same as ICS slide (H,C,ST)
CCHH STTT

21
Q

Leukotriene Modifiers

A

-montelukast (Singulair®)
-zafirlukast (Accolate®)
-zileuton (Zyflo CR®)

AE:
-elevated LFTs with ZZ
-airway infection, fever, rash, diarrhea with ZZ
-BBW for montelukast: behavior and mood changes in children

zileuton NEED LFT monitoring

DDI: warfarin, theo, erythromycin (E only for ZA)

22
Q

ICS-SABA

A

-Albuterol/budesonide inhalation aerosol 90mg/80mcg (Airsupra®)

18+ only
-2 puffs prn, max 12 puffs in 24 hours

same AE for ICS/SABA
-NN TT HH, (H,C,ST)

23
Q

Biologics

A

Anti-IgE
-Omalizumab, Zolair

subQ, IV

severe asthma only

AE
-Injection site rxns
-Anaphylaxis is rare
-Headaches

24
Q

Non Pharm Strategies

A

-Smoking cessation
-Physical activity, regular exercise
-Avoid meds/allergens
-Weight reduction (obese)
-Dealing with emotion/stress